Cited 21 times in

Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea

DC Field Value Language
dc.contributor.author강신욱-
dc.contributor.author권영은-
dc.contributor.author기연경-
dc.contributor.author박정탁-
dc.contributor.author유태현-
dc.contributor.author윤창연-
dc.contributor.author한승혁-
dc.date.accessioned2017-02-24T08:11:48Z-
dc.date.available2017-02-24T08:11:48Z-
dc.date.issued2016-
dc.identifier.issn0025-7974-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/146580-
dc.description.abstractAlthough numerous studies have tried to elucidate the best dialysis modality in end-stage renal disease patients with diabetes, results were inconsistent and varied with the baseline characteristics of patients. Furthermore, none of the previous studies on diabetic dialysis patients accounted for the impact of glycemic control. We explored whether glycemic control had modifying effect on mortality between hemodialysis (HD) and peritoneal dialysis (PD) in incident dialysis patients with diabetes. A total of 902 diabetic patients who started dialysis between August 2008 and December 2013 were included from a nationwide prospective cohort in Korea. Based on the interaction analysis between hemoglobin A1c (HbA1c) and dialysis modalities for patient survival (P for interaction = 0.004), subjects were stratified into good and poor glycemic control groups (HbA1c< or ≥8.0%). Differences in survival rates according to dialysis modalities were ascertained in each glycemic control group after propensity score matching. During a median follow-up duration of 28 months, the relative risk of death was significantly lower in PD compared with HD in the whole cohort and unmatched patients (whole cohort, hazard ratio [HR] = 0.65, 95% confidence interval [CI] = 0.47-0.90, P = 0.01; patients with available HbA1c [n = 773], HR = 0.64, 95% CI = 0.46-0.91, P = 0.01). In the good glycemic control group, there was a significant survival advantage of PD (HbA1c <8.0%, HR = 0.59, 95% CI = 0.37-0.94, P = 0.03). However, there was no significant difference in survival rates between PD and HD in the poor glycemic control group (HbA1c ≥8.0%, HR = 1.21, 95% CI = 0.46-2.76, P = 0.80). This study demonstrated that the degree of glycemic control modified the mortality risk between dialysis modalities, suggesting that glycemic control might partly contribute to better survival of PD in incident dialysis patients with diabetes.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherLippincott Williams & Wilkins-
dc.relation.isPartOfMEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAged-
dc.subject.MESHDiabetes Mellitus/blood*-
dc.subject.MESHDiabetes Mellitus/mortality*-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHGlycated Hemoglobin A/metabolism*-
dc.subject.MESHHumans-
dc.subject.MESHKidney Failure, Chronic/blood*-
dc.subject.MESHKidney Failure, Chronic/mortality*-
dc.subject.MESHKidney Failure, Chronic/therapy-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPeritoneal Dialysis-
dc.subject.MESHPropensity Score-
dc.subject.MESHProspective Studies-
dc.subject.MESHRenal Dialysis/methods*-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRisk Factors-
dc.subject.MESHSurvival Rate-
dc.titleGlycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea-
dc.typeArticle-
dc.publisher.locationUnited States-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Internal Medicine-
dc.contributor.googleauthorMi Jung Lee-
dc.contributor.googleauthorYoung Eun Kwon-
dc.contributor.googleauthorKyoung Sook Park-
dc.contributor.googleauthorYoun Kyung Kee-
dc.contributor.googleauthorChang-Yun Yoon-
dc.contributor.googleauthorIn Mee Han-
dc.contributor.googleauthorSeung Gyu Han-
dc.contributor.googleauthorHyung Jung Oh-
dc.contributor.googleauthorJung Tak Park-
dc.contributor.googleauthorSeung Hyeok Han-
dc.contributor.googleauthorTae-Hyun Yoo-
dc.contributor.googleauthorYong-Lim Kim-
dc.contributor.googleauthorYon Su Kim-
dc.contributor.googleauthorChul Woo Yang-
dc.contributor.googleauthorNam-Ho Kim-
dc.contributor.googleauthorShin-Wook Kang-
dc.identifier.doi10.1097/MD.0000000000003118-
dc.contributor.localIdA00053-
dc.contributor.localIdA00232-
dc.contributor.localIdA00276-
dc.contributor.localIdA01654-
dc.contributor.localIdA02526-
dc.contributor.localIdA02613-
dc.contributor.localIdA04304-
dc.relation.journalcodeJ02214-
dc.identifier.eissn1536-5964-
dc.identifier.pmid26986162-
dc.contributor.alternativeNameKang, Shin Wook-
dc.contributor.alternativeNameKwon, Young Eun-
dc.contributor.alternativeNameKee, Youn Kyung-
dc.contributor.alternativeNamePark, Jung Tak-
dc.contributor.alternativeNameYoo, Tae Hyun-
dc.contributor.alternativeNameYoon, Chang Yun-
dc.contributor.alternativeNameHan, Seung Hyeok-
dc.contributor.affiliatedAuthorKang, Shin Wook-
dc.contributor.affiliatedAuthorKwon, Young Eun-
dc.contributor.affiliatedAuthorKee, Youn Kyung-
dc.contributor.affiliatedAuthorPark, Jung Tak-
dc.contributor.affiliatedAuthorYoo, Tae Hyun-
dc.contributor.affiliatedAuthorYoon, Chang Yun-
dc.contributor.affiliatedAuthorHan, Seung Hyeok-
dc.citation.volume95-
dc.citation.number11-
dc.citation.startPage3118-
dc.identifier.bibliographicCitationMEDICINE, Vol.95(11) : 3118, 2016-
dc.date.modified2017-02-24-
dc.identifier.rimsid46389-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.